Further studies showed a-catenin inhibited Yap activity and tumour progression through constitutively anchoring Yap to adherens junctions, or directly inhibiting an Itgb4-Src-Yap signalling pathway [39–41]. The gene discussed is YAP1; the disease is neoplasm.